News

1. Tessa M. Meyer, MD, BCCS, Achieves Prominent Placement in The Wall Street Journal

   Marquis Who's Who is proud to endorse Tessa M. Meyer, MD, BCCS, in the Texas Edition of The Wall Street Journal

2. Clinician Anita Davidson and Biochemist Dr. Don Davidson Advance CBT300, an Investigational Biologic Candidate for Cancer Recurrence and Drug Resistance

   Creative Biotherapeutics, LLC, led by Anita Davidson, DPT, and Dr. Don Davidson, is advancing CBT300, an investigational biologic therapeutic candidate targeting drug resistance, immune evasion, recurrence, and metastasis in cancer treatment failure.

3. AdvantaPure™ Launches Sustainable Tubing Product - EcoFlex™

   AdvantaPure, a Division of NewAge Industries, Inc™. Launches Sustainable Tubing Product with Regional Distributors Carolina Components Group at ISPE CaSA

4. SecQube Expands Global Footprint with Official Launch in the United States

   SecQube, a leading innovator in AI-driven cybersecurity solutions, is proud to announce its official launch in the United States.

5. Global Vision Technologies Moves Core Infrastructure to Microsoft Azure to Deliver Faster Performance, Greater Scalability, and Enhanced Security

   Cloud migration strengthens performance, resiliency, and scalability for FAMCare agencies while accelerating delivery of next-generation reporting and configuration tools.

6. Behrooz Kamgar-Parsi, PhD, Featured in The Wall Street Journal

   Marquis Who's Who proudly endorsed Behrooz Kamgar-Parsi, PhD, in the Eastern Edition of The Wall Street Journal

7. Marquis Who's Who Honors Joseph Soblosky, PhD, for Expertise in Neuroscience Research and Brain Neurotransmitter and their Receptor Analyses

   Joseph Soblosky, PhD, is a distinguished professional in the field of neuropharmacology recognized for his expertise in brain neurotransmitter and receptor analyses

8. Creative Biolabs Announces Comprehensive Updates to Bispecific Antibody Development Services

   Creative Biolabs has announced the expansion of its end-to-end bispecific antibody (BsAb) development service.

9. STEMart Enhances Genetic Toxicology Services with Advanced In Vivo Mouse Micronucleus Test for Medical Device Safety

   STEMart announces In Vivo Mouse Micronucleus Test service to help medical device manufacturers identify potential genotoxic risks.

10. Creative Diagnostics Announces Integrated CRO Platform to Accelerate AI-Powered Infectious Disease Drug Discovery

    Creative Diagnostics launches An Integrated CRO Platform for AI-powered Infectious Disease Drug Discovery.